Revisiting atherosclerosis and dementia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Towards a Multidimensional Model of Neurocognitive Disorders (MOND Model): Integrating Evidence from a Critical Review into a Model for Future Research.Journal of personalized medicine · 2026
   Review
2. Consumption of coffee and tea and the risk of developing neurodegenerative diseases: a cohort study in the UK biobank.Nutrition journal · 2026
   Article
3. Cerebral blood flow and energy demand: imaging insights into neurovascular function.Neurophotonics · 2025
   Review
4. Estimation of Machine Learning-Based Models to Predict Dementia Risk in Patients With Atherosclerotic Cardiovascular Diseases: UK Biobank Study.JMIR aging · 2025
   Article
5. Identifying modifiable factors associated with neuroimaging markers of brain health.CNS neuroscience & therapeutics · 2024
   Article
6. Dementia risk in patients with heart disease and depression.Dementia & neuropsychologia · 2023
   Article
7. Editorial: Epidemiology and clinical researches in atherosclerosis and cardiovascular disease.Frontiers in cardiovascular medicine · 2023
   Article
8. There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness.American journal of preventive cardiology · 2022
   Review
9. Stroke incidence and cognitive outcomes of intracranial atherosclerotic stenosis: study protocol for a multicenter, prospective, observational cohort study.Annals of translational medicine · 2022
   Article
10. [Relationship between Oral Microbiota and Alzheimer's Disease].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2022
    Review
11. Neuroprotective Effect of SGLT2 Inhibitors.Molecules (Basel, Switzerland) · 2021
    Review
12. Assessing cerebral arterial pulse wave velocity using 4D flow MRI.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
13. Macrophages, Metabolites, and Nucleosomes: Chromatin at the Intersection between Aging and Inflammation.International journal of molecular sciences · 2021
    Review
14. A Review on Joint Carotid Intima-Media Thickness and Plaque Area Measurement in Ultrasound for Cardiovascular/Stroke Risk Monitoring: Artificial Intelligence Framework.Journal of digital imaging · 2021
    Review
15. Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy.Frontiers in aging neuroscience · 2021
    Article
16. Microfluidic Protein Imaging Platform: Study of Tau Protein Aggregation and Alzheimer's Drug Response.Bioengineering (Basel, Switzerland) · 2020
    Article

Corrections and comments

• Comment on
  Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain.2020

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as